Objective The proposed project aims to put the basis for the commercialization of a new kit for the definitive diagnosis of Sjogren’s Syndrome, an autoimmune disease with an high incidence in the population (up to 4%) and characterised by serious complications. The product relies on proteinaceous nanomaterials produced in plants, namely virus-based particles, characterised by superior performance in ELISA tests compared to actual diagnostic systems. One of the main advantages of the proposed product compared to existing ones is that it gets rid of the need of a biopsy procedure for disease diagnosis while increasing the specificity of diagnostic outcomes.The project aims to explore the potential of this novel and high-performing product in the EU and US markets, given that the patent has been already filed and that the actual company asset is already capable of supporting the forecast needs of the kit in the EU market. Furthermore, the π project will help the company in envisaging several aspects before the product commercialization, spamming from a clear definition of the normative procedure for its commercialization in different countries to the set-up of a business strategy for its distribution. Fields of science social sciencessociologysocial issuessocial inequalitiesmedical and health sciencesbasic medicineimmunologyautoimmune diseasesmedical and health sciencesclinical medicineoncologymedical and health sciencesclinical medicineallergologyengineering and technologymedical engineeringmedical laboratory technologylaboratory samples analysis Programme(s) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.3.1.3. - Treating and managing disease Topic(s) PHC-12-2015-1 - Clinical research for the validation of biomarkers and/or diagnostic medical devices Call for proposal H2020-SMEInst-2014-2015 See other projects for this call Sub call H2020-SMEINST-1-2015 Funding Scheme SME-1 - SME instrument phase 1 Coordinator Officina Biotecnologica S.R.L. Net EU contribution € 50 000,00 Address San pietro in cariano, villa lebrecht 37029 Verona Italy See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Nord-Est Veneto Verona Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 21 429,00
